J&J | JNJ - Ordinary Share Capital


J&J reported $2.41B in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 608K Jun/2026
Abbott USD 1.74B 2.94M Mar/2026
Amgen USD 541M 0 Sep/2026
AstraZeneca USD 1.55B 28K Sep/2026
Baxter International USD 517M 549K Jun/2026
Bayer EUR 982.42M 0 Sep/2026
Becton, Dickinson and Co. USD 272.39M 98.21M Sep/2026
Biogen USD 146.7M 200K Sep/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
Bristol-Myers Squibb USD 2.04B 7M Jun/2026
CONMED USD 29.87M 118K Sep/2026
Cooper Companies USD 190.1M 5.01M Jun/2026
Dexcom USD 377.4M 8.5M Jun/2026
Edwards Lifesciences USD 576.6M 400K Jun/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
GlaxoSmithKline GBP 2.02B 2.05B Sep/2026
Globus Medical USD 132.66M 1.59M Sep/2026
Insulet USD 69.37M 16K Sep/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
Intuitive Surgical USD 353.28M 885K Sep/2026
J&J USD 2.41B 1.64M Jun/2026
Medtronic USD 1.28B 130K Jun/2026
Merck USD 2.47B 1.05M Jun/2026
Merit Medical Systems USD 59.71M 55K Jun/2026
Novartis USD 1.89B 12.09M Sep/2026
Pfizer USD 5.7B 0 Jun/2026
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Sanofi EUR 1.2B 0 Sep/2026
Stryker USD 383.4M 416K Jun/2026
Tandem Diabetes Care USD 69.76M 217K Sep/2026
Teva Pharmaceutical Industries USD 1.17B 2M Sep/2026
Vertex Pharmaceuticals USD 253.5M 200K Sep/2026
Zimmer Biomet Holdings USD 190.1M 3.3M Sep/2026
Zoetis USD 407.49M 6.67M Sep/2026